Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 09 04:00PM ET
6.11
Dollar change
-0.31
Percentage change
-4.83
%
IndexRUT P/E- EPS (ttm)-1.09 Insider Own49.96% Shs Outstand27.82M Perf Week-11.83%
Market Cap178.41M Forward P/E- EPS next Y-0.86 Insider Trans-4.19% Shs Float14.61M Perf Month-13.70%
Income-29.90M PEG- EPS next Q-0.27 Inst Own37.76% Short Float3.65% Perf Quarter-17.54%
Sales71.82M P/S2.48 EPS this Y13.84% Inst Trans13.44% Short Ratio8.77 Perf Half Y-57.92%
Book/sh0.34 P/B18.01 EPS next Y21.41% ROA-30.41% Short Interest0.53M Perf Year-12.84%
Cash/sh1.90 P/C3.21 EPS next 5Y- ROE-192.19% 52W Range5.75 - 18.15 Perf YTD-40.74%
Dividend Est.- P/FCF- EPS past 5Y-0.33% ROI-36.55% 52W High-66.34% Beta1.79
Dividend TTM- Quick Ratio5.47 Sales past 5Y16.39% Gross Margin74.15% 52W Low6.26% ATR (14)0.53
Dividend Ex-Date- Current Ratio6.37 EPS Y/Y TTM35.99% Oper. Margin-34.50% RSI (14)32.97 Volatility7.44% 7.56%
Employees171 Debt/Eq7.46 Sales Y/Y TTM30.75% Profit Margin-41.63% Recom1.29 Target Price14.57
Option/ShortYes / Yes LT Debt/Eq7.28 EPS Q/Q27.30% Payout- Rel Volume1.07 Prev Close6.42
Sales Surprise5.24% EPS Surprise13.33% Sales Q/Q16.63% EarningsAug 13 AMC Avg Volume60.79K Price6.11
SMA20-11.74% SMA50-14.33% SMA200-40.96% Trades Volume64,525 Change-4.83%
Date Action Analyst Rating Change Price Target Change
Mar-14-24Upgrade Wells Fargo Equal Weight → Overweight $16 → $20
Jan-30-24Initiated Leerink Partners Outperform $22
Nov-10-23Initiated Cantor Fitzgerald Overweight $11
Aug-24-23Upgrade Morgan Stanley Underweight → Equal-Weight $5 → $6
Feb-22-23Initiated Lake Street Buy $10
Apr-06-22Initiated Wolfe Research Outperform $13
Jan-19-22Downgrade Wells Fargo Overweight → Equal Weight $11
Jan-07-22Downgrade Morgan Stanley Equal-Weight → Underweight $17 → $12
Nov-11-21Downgrade Morgan Stanley Overweight → Equal-Weight
Aug-18-21Initiated Robert W. Baird Outperform $26
Oct-03-24 07:04PM
Sep-04-24 04:05PM
Aug-27-24 04:05PM
Aug-22-24 04:05PM
Aug-20-24 07:37AM
04:05PM Loading…
Aug-13-24 04:05PM
Jul-23-24 04:05PM
May-14-24 04:05PM
May-13-24 10:46AM
06:53AM
May-10-24 03:38PM
May-09-24 03:47AM
May-08-24 04:05PM
Apr-17-24 04:05PM
Apr-04-24 12:20PM
04:05PM Loading…
Mar-27-24 04:05PM
Mar-07-24 11:44AM
Mar-06-24 06:28AM
Mar-05-24 09:52PM
04:05PM
02:00PM
Feb-23-24 05:15AM
Feb-15-24 04:05PM
Feb-07-24 03:13AM
Feb-01-24 11:02PM
Jan-08-24 07:03AM
Dec-29-23 09:01PM
Dec-21-23 07:07AM
Dec-19-23 04:30PM
Dec-04-23 05:07PM
08:00AM Loading…
Dec-01-23 08:00AM
Nov-21-23 08:00AM
Nov-07-23 09:45AM
Nov-06-23 04:33PM
04:03PM
Oct-26-23 10:33AM
Oct-17-23 04:05PM
Oct-16-23 05:01PM
Oct-05-23 01:02AM
Sep-29-23 03:16PM
Sep-20-23 04:05PM
Aug-24-23 04:05PM
Aug-13-23 08:03AM
Aug-08-23 04:03PM
Jul-19-23 04:03PM
Jul-18-23 04:05PM
Jun-28-23 04:03PM
May-24-23 04:05PM
May-05-23 10:13AM
May-04-23 04:05PM
Apr-17-23 04:05PM
06:39AM
Apr-03-23 04:05PM
Mar-30-23 07:32AM
Mar-06-23 05:52AM
Mar-03-23 06:07AM
Mar-02-23 04:05PM
Feb-10-23 08:00AM
Jan-09-23 04:03PM
Dec-21-22 04:03PM
Nov-30-22 08:00AM
Nov-11-22 05:25AM
Nov-08-22 04:03PM
Nov-04-22 04:03PM
Oct-25-22 04:03PM
Oct-21-22 06:44AM
Oct-11-22 08:00AM
Aug-23-22 04:06PM
Aug-12-22 02:31AM
Aug-11-22 04:02PM
04:02PM
Jul-21-22 04:03PM
May-13-22 03:38PM
08:00AM
04:30AM
May-12-22 04:03PM
May-04-22 08:00AM
Apr-21-22 04:03PM
Mar-21-22 07:49AM
06:20AM
Mar-10-22 08:00PM
04:02PM
Jan-27-22 04:03PM
Jan-11-22 04:03PM
Dec-16-21 07:00AM
Nov-11-21 10:00AM
Nov-10-21 04:03PM
04:02PM
Oct-20-21 04:05PM
Oct-19-21 04:03PM
Sep-20-21 09:34AM
Aug-23-21 04:03PM
Aug-13-21 08:30AM
Aug-12-21 04:03PM
Aug-04-21 08:00AM
Jul-22-21 04:03PM
05:37AM
Jul-03-21 07:07AM
Jun-30-21 08:00AM
Jun-03-21 07:00AM
NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components, which include the RNS neurostimulator as well as depth and cortical strip leads. The firm's RNS System is designed for the treatment of medically refractory partial epilepsy and includes implantable and external products. The company was founded by Rebecca L. Kuhn, Frank M. Fischer on November 19, 1997 and is headquartered in Mountain View, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KCK LTD.10% OwnerSep 25 '24Sale6.605,85838,6635,578,443Oct 03 04:15 PM
KCK LTD.10% OwnerSep 26 '24Sale6.625,82138,5355,572,622Oct 03 04:15 PM
KCK LTD.10% OwnerSep 27 '24Sale6.635,05933,5415,567,563Oct 03 04:15 PM
KCK LTD.10% OwnerAug 30 '24Sale7.764,31433,4775,589,459Oct 03 04:15 PM
KCK LTD.10% OwnerOct 01 '24Sale6.774,88233,0515,557,932Oct 03 04:15 PM
KCK LTD.10% OwnerSep 30 '24Sale6.734,74931,9615,562,814Oct 03 04:15 PM
KCK LTD.10% OwnerOct 02 '24Sale6.873,84326,4015,554,089Oct 03 04:15 PM
KCK LTD.10% OwnerSep 03 '24Sale7.602,09315,9075,587,366Oct 03 04:15 PM
KCK LTD.10% OwnerSep 13 '24Sale7.591,99315,1275,585,348Oct 03 04:15 PM
KCK LTD.10% OwnerSep 20 '24Sale7.507655,7385,584,583Oct 03 04:15 PM
KCK LTD.10% OwnerSep 23 '24Sale7.542822,1265,584,301Oct 03 04:15 PM
KCK LTD.10% OwnerSep 04 '24Sale7.50141055,587,352Oct 03 04:15 PM
KCK LTD.10% OwnerSep 06 '24Sale7.5011825,587,341Oct 03 04:15 PM
KCK LTD.10% OwnerAug 30 '24Proposed Sale7.76190,0001,474,400Oct 03 04:05 PM
ORBIMED ADVISORS LLC10% OwnerMay 01 '24Sale14.0215,690219,9743,419,851May 03 05:16 PM
ORBIMED ADVISORS LLC10% OwnerMay 02 '24Sale14.018,842123,8763,411,009May 03 05:16 PM
ORBIMED ADVISORS LLC10% OwnerMay 03 '24Sale14.034,67465,5763,406,335May 03 05:16 PM
ORBIMED ADVISORS LLC10% OwnerApr 24 '24Sale14.061,78125,0413,435,541Apr 26 05:01 PM
ORBIMED ADVISORS LLC10% OwnerApr 22 '24Sale14.0524,609345,7563,459,113Apr 23 06:38 PM
ORBIMED ADVISORS LLC10% OwnerApr 23 '24Sale14.2921,791311,3933,437,322Apr 23 06:38 PM
ORBIMED ADVISORS LLC10% OwnerApr 19 '24Sale14.0218,253255,9073,483,722Apr 23 06:38 PM
ORBIMED ADVISORS LLC10% OwnerApr 16 '24Sale14.0114,069197,1073,504,898Apr 18 05:10 PM
ORBIMED ADVISORS LLC10% OwnerApr 18 '24Sale14.062,62336,8793,501,975Apr 18 05:10 PM
ORBIMED ADVISORS LLC10% OwnerApr 17 '24Sale14.153004,2453,504,598Apr 18 05:10 PM
ORBIMED ADVISORS LLC10% OwnerApr 11 '24Sale14.49461,8996,692,9173,542,068Apr 15 05:25 PM
ORBIMED ADVISORS LLC10% OwnerApr 12 '24Sale14.4223,101333,1163,518,967Apr 15 05:25 PM
Morrell MarthaChief Medical OfficerFeb 02 '24Sale15.0714,143213,12281,208Feb 06 07:16 PM
Morrell MarthaChief Medical OfficerFeb 05 '24Sale15.173,44652,27877,762Feb 06 07:16 PM
Morrell MarthaChief Medical OfficerJan 30 '24Sale15.1011,262170,00497,937Feb 01 09:47 PM
Morrell MarthaChief Medical OfficerJan 31 '24Sale15.081,92328,99096,014Feb 01 09:47 PM
Morrell MarthaChief Medical OfficerFeb 01 '24Sale15.046639,97195,351Feb 01 09:47 PM
Morrell MarthaChief Medical OfficerJan 24 '24Sale15.0382712,426109,200Jan 26 06:04 PM
Morrell MarthaChief Medical OfficerJan 25 '24Sale15.00115109,199Jan 26 06:04 PM
Morrell MarthaChief Medical OfficerDec 27 '23Sale10.1213,300134,648110,027Dec 28 05:47 PM
Morrell MarthaChief Medical OfficerDec 26 '23Sale10.001021,020123,327Dec 28 05:47 PM
Morrell MarthaChief Medical OfficerDec 20 '23Sale10.142,73027,695123,429Dec 22 04:21 PM
Morrell MarthaChief Medical OfficerDec 06 '23Sale8.1611,00589,773126,159Dec 07 04:07 PM
KCK LTD.10% OwnerNov 30 '23Sale8.847,28264,3735,597,014Dec 01 09:57 PM
KCK LTD.10% OwnerNov 29 '23Sale8.725,64449,2165,604,296Dec 01 09:57 PM
KCK LTD.10% OwnerDec 01 '23Sale8.733,24128,2945,593,773Dec 01 09:57 PM
KCK LTD.10% OwnerNov 27 '23Sale8.966,49058,1505,614,621Nov 29 05:35 PM
KCK LTD.10% OwnerNov 28 '23Sale8.754,68140,9595,609,940Nov 29 05:35 PM